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Sunday, February 8, 2015 121aactivation, increase channel deactivation, and shift the G-V curve to more
positive voltages. A number of reports have also shown that hydrogen can
reduce HERG current by a mechanism that does not involve an effect on
channel deactivation and which likely involves pore block. We have shown
previously that reducing extracellular potassium results in a significant in-
crease in HERG current reduction by a number of extracellular divalent
ions, including calcium, magnesium, cobalt, manganese, and hydrogen.
We show here that current reduction of WT HERG by extracellular calcium
is voltage dependent and that current reduction of the HERG mutant
G628CS631A is significantly reduced compared to WT at all voltages tested.
In addition current reduction of the HERG mutant S631A shows altered
voltage dependence compared to WT HERG. These results suggest that cal-
cium and other divalent ions can block HERG and may interact with the
outer pore of the HERG channel.
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Voltage sensor relaxation may contribute to the slow deactivation kinetics of
hERG channels1. Relaxation stabilizes the voltage sensor in the activated state
resulting in a mode-shift, where the voltage-dependence of channel deactiva-
tion is shifted ~-30 mV compared with that of channel activation. Voltage
clamp fluorimetry (VCF) reports of voltage sensor movement show a similar
shift in the voltage-dependence of S4 return compared with its activation.
However, the mechanism underlying voltage sensor relaxation in hERG is un-
known. In Shaker channels, voltage sensor relaxation has been shown to be
sensitive to the length and composition of the S3-S4 linker2. Here, we as-
sessed the role of S3-S4 linker length and composition in voltage sensor relax-
ation in hERG channels using two constructs: a chimera with the 9 residue
hERG S3-S4 linker substituted with the 31 residue Shaker S3-S4 linker; the
other with the 9 residues of the hERG S3-S4 linker mutated to glycine resi-
dues. In both cases, the robust shifts in the voltage-dependence of ionic cur-
rent deactivation relative to that of activation were preserved (35 and 29
mV in the 31 residue Shaker linker construct (n¼4) and the 9 glycine
construct (n¼5), respectively), suggesting that length and composition of
the S3-S4 linker are not important mediators of hERG channel relaxation.
Instead, we demonstrate that the ionic current mode-shift is reduced by
external protons in a pH-dependent manner with a pKa of 5.5 (n¼5). Further-
more, VCF recordings of voltage sensor movement show that acidic pH
directly inhibits voltage sensor relaxation. These data suggest that external
protons modify voltage sensor relaxation by destabilizing the relaxed confor-
mation and reveal a mechanism by which acidic pH may accelerate hERG
channel deactivation gating kinetics.
1.Tan et al., J.Gen.Physiol. 140:293-306, 2012
2.Priest et al., Biophys.J. 105:2312-2322, 2013
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Drug interactions with cardiac ion channels can cause disturbances to normal
electrical activity in the heart. In particular, hERG channel block has been
linked with QT prolongation and increased pro-arrhythmic risk. Conse-
quently, hERG channel screening, quantifying drug block at different drug
concentrations, forms a routine part of cardiovascular safety assessment.
Recent initiatives led by the US Food and Drug Administration (FDA) aim
to reform the current safety assessment guidelines and in silico approaches
are envisaged to form an integral part of the new regime (Sager et al., Am
Heart J., 2014).
Mathematical ion channel representations, embedded within action potential
models, are typically constructed through fitting to patch clamp data that
are acquired by applying a series of voltage-step protocols. But different
models exhibit disparate behaviour under non-standard protocols; including
physiologically relevant action potential clamps, or clamps mimicking ar-
rhythmogenic behaviour. We demonstrate the influence the choice of hERG
channel representation can have on action potentials simulated from a math-
ematical ventricular myocyte model when predicting drug-induced effects;
indicating the necessity of including accurate descriptions of hERG channel
kinetics.We present novel rapidly fluctuating voltage-clamp protocols, designed
mathematically to enable a robust model of hERG channel kinetics to be
determined, on a cell-specific basis. The protocols have been tested in manual
patch clamp experiments, using hERG-1a transfected HEK 293 cells. The
approach will be extended to determine compound-specific models describing
hERG channel kinetics in the presence of different drugs, which may enhance
the predictive ability of in silico approaches used for cardiovascular safety
assessment.
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Human ether-a-go-go-related gene 1 (hERG1) Kþ channels mediate repo-
larization of action potentials in cardiomyocytes. A refined mechanistic
understanding of the action of hERG1 agonists may assist development
of novel compounds for treatment of arrhythmia associated with acquired
or congenital long QT syndrome. RPR-260243 [(3R,4R)-4-[3-(6-meth
oxy-quinolin-4-yl)-3-oxo-propyl]-1-[3-(2,3,5 trifluorophenyl)-prop-2-ynyl]-
piperidine-3-carboxylic acid] (RPR) profoundly slows deactivation and
modestly attenuates fast C-type inactivation of hERG1 channels without
affecting its kinetics. A Markov model of channel gating incorporating
two open states reproduced these experimental findings. A binding site for
RPR has been localized to a hydrophobic pocket between two adjacent
hERG1 subunits. Accordingly, one homotetrameric hERG1 channel contains
four identical RPR binding sites. In this study, the stoichiometric basis of
RPR-altered hERG1 channel currents was investigated. Concatenated
hERG1 tetramers incorporating a variable number of wild-type subunits
and mutant subunits (L553A to prevent RPR binding) were constructed
and heterologously expressed in Xenopus oocytes. RPR slowed the rate of
hERG1 channel deactivation as a function of the number of wild-type sub-
units (i.e., accessible RPR binding sites) contained within a tetramer. Occu-
pancy of all four available binding sites was required to attain maximum
effect. In contrast, occupancy of only three binding sites was sufficient to
achieve the maximum shift (þ24 mV) in the voltage required for half-
maximal inactivation. The distinct subunit stoichiometries associated with
RPR-induced changes in hERG1 deactivation and inactivation reflects the
different structural basis of the activation (S6 bundle crossing) and inactiva-
tion (selectivity filter) gates.
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Dofetilide is an antiarrhythmic agent used for the maintenance and protection
of sinus rhythm from atrial fibrillations and flutters in individuals. However,
dofetilide is better known for its arrhythogenic activity and blockade of IKr
currents and is limited in clinical use. An inadvertent drug blockade of
hERG channel predisposes to drug-induced Long-QT2 syndrome in humans.
It is well established that dofetilide reversibly binds with moderate-to-high af-
finity to an open state of hERG1 reversibly but irreversibly blocks open-
inactivated state. Here, we used a combination of MD simulations and free
energy simulations to unravel key determinants of state-dependent blockade
of hERG1. It was found that inactivation of the channel and formation of
open-inactivate state of hERG1 leads to narrowly localized high-affinity bind-
ing pocket for dofetilide. The corresponding Potential of Mean Force (PMF)
for drug dissociation from open state of the channel is markedly different. It
shows shallow but broad minima. To place findings from atomistic simula-
tions to cellular context we performed kinetic modeling of IKr currents using
Markov-net models developed previously. The results were compared to elec-
trophysiological recordings of dofetilide binding to WT and 656C mutants of
hERG1 channel.
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We have recently proposed that the linker region between RCK domains in
the cytoplasmic portion of BK channels consists of a Cytochrome-c-like
